Comment on “Cost-Effectiveness of Photobiomodulation for Intermediate Dry Age-Related Macular Degeneration: A Model-Based Analysis Using the LIGHTSITE III 24-Month Trial”

Dipeng Li; Shengping Hu; Mao Wu

doi:10.1016/j.ajo.2026.08.051

Enriched record

Comment on “Cost-Effectiveness of Photobiomodulation for Intermediate Dry Age-Related Macular Degeneration: A Model-Based Analysis Using the LIGHTSITE III 24-Month Trial”

Dipeng Li, Shengping Hu, Mao Wu

American Journal of Ophthalmology2026doi:10.1016/j.ajo.2026.08.051

Citation graph

Abstract

No public abstract is available from the verified source records.

Authors

Dipeng Li#1 Shengping Hu#2 Mao Wu#3

Institutions

No ROR-resolved institution is linked to this work yet.

Provenance

crossref

Confidence 100%

pubmed

Confidence 98%

europepmc

Confidence 96%

unpaywall

Confidence 95%

datacite

Confidence 0%

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

Cost-Effectiveness of Photobiomodulation for Intermediate Dry Age-Related Macular Degeneration: A Model-Based Analysis Using the LIGHTSITE III 24-Month Trial

10.1016/j.ajo.2026.07.035 · 2026

Visual functioning and geographic atrophy imaging characteristics in age-related macular degeneration

10.1007/s00417-025-07084-1 · 2026

Patient-reported visual difficulties associated with geographic atrophy from age-related macular degeneration

10.1007/s10792-025-03781-2 · 2025

Additional external references

No additional external references are available.